Interleukin-18 and interleukin-12 synergize to stimulate the production of vascular permeability factor by T lymphocytes in normal subjects and in patients with minimal-change nephrotic syndrome

Nephron

Volumn 85, Issue 2, 2000, Pages 127-133

  Matsumoto, Koichi ^a   Kanmatsuse, Katsuo ^b  

^a SAITAMA PREFECTURAL UNIVERSITY   (Japan)

^b NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Interleukin 12; Interleukin 18; Minimal change nephrotic syndrome; T cells; Vascular permeability factor

Indexed keywords

CONCANAVALIN A; INTERLEUKIN 12; INTERLEUKIN 18; NEUTRALIZING ANTIBODY; VASCULOTROPIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MINIMAL CHANGE GLOMERULONEPHRITIS; NEPHROTIC SYNDROME; PRIORITY JOURNAL; PROTEIN INDUCTION; T LYMPHOCYTE;

EID: 0034038384     PISSN: 00282766     EISSN: None     Source Type: Journal    
DOI: 10.1159/000045645     Document Type: Article

References (13)

1. Lagrue G, Xheneumont S, Branelle A, Hirbec G, Weil B: A vascular permeability factor elaborated from lymphocytes, I. Demonstration in patients with nephrotic syndrome. Biomedicine 1975;23:37-40.
2. Heslan J-MJ, Branellec A, Pilatte Y, Lang P, Lagrue G: Differentiation between vascular permeability factor and IL-2 in lymphocyte supernatants from patients with minimal-change nephrotic syndrome. Clin Exp Immunol 1991;86:157-162.
3. Yoshizawa N, Kusumi Y, Matsumoto K, Ohshima S, Takeuchi A, Kawamura O, Kubota T, Kundo S, Niwa H: Studies of a glomerular permeability factor in patients with minimal-change nephrotic syndrome. Nephron 1989;51: 370-376.
4. Boulton-Jones JM, Tulloch I, Dorc B, McLay A: Changes in the glomerular capillary wall induced by lymphocyte products and serum of nephrotic patients. Clin Nephrol 1983;20:72-77.
5. Matsumoto K, Kanmatsuse K: Increased IL-12 release by monocytes in nephrotic patients. Clin Exp Immunol 1999;117:361-367.
6. Yoshimoto T, Takeda K, Tanaka T, Ohkusu K, Kashiwamura S, Okamura H, Akira S, Nakanishi K: IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: Synergism with IL-18 for IFN-γ production. J Immunol 1998;161:3400-3407.
7. Matsumoto K, Ohi H, Kanmatsuse K: Interleukin-12 up-regulates the release of vascular permeability factor by peripheral blood mononuclear cells from patients with lipoid nephrosis. Nephron 1998;78:403-409.
8. Matsumoto K, Ohi H, Kanmatsuse K: Interleukin-4 cooperates with interleukin-10 to inhibit vascular permeability factor release by peripheral blood mononuclear cells from patients with minimal-change nephrotic syndrome. Am J Nephrol 1999;19:21-27.
9. Danielpour D, Roberts AB: Specific and sensitive quantitation of transforming growth factor β3 by sandwich enzyme-linked immunosorbent assay. J Immunol Methods 1995;180: 265-272.
10. Okamura H, Tsutsui H, Komatsu T, Yutsudo M, Hakura A, Tanimoto T, Torigoe K, Okura T, Nukada Y, Hattori K: Cloning of a new cytokine that induces IFN-γ production by T cells. Nature 1995;378:88-91.
11. Kohno K, Kataoka J, Ohtsuki T, Suemoto Y, Okamoto I, Usui M, Ikeda M, Kurimoto M: IFN-γ-inducing factor (IGIF) is a costimulatory factor on the activation of Th1 but not Th2 cells and exerts its effect independently of IL-12. J Immunol 1997;158:1541-1550.
12. Daniel V, Trautmann Y, Konrad M, Nayir A, Schräder K: T-lymphocyte populations, cytokines and other growth factors in serum and urine of children with idiopathic nephrotic syndrome. Clin Nephrol 1997;47:289-297.
13. Schmitt E, Hoehn P, Huels C, Goedert S, Palm N, Rüde E, Germann T: T helper type 1 development of naive CD4+ T cells requires the coordinate action of interleukin-12 and interferon-γ and is inhibited by transforming growth factor-β. Eur J Immunol 1994;24:793-798.